You are here

• Home
• Therapy Areas
• Cardiovascular

• A Randomised, Single-Blind, Placebo-Controlled, Phase IIA Study to Assess the Safety and Tolerability after Multiple Oral Doses of AZD1656 in Patients with Type 2 Diabetes Mellitus Treated with Metformin

Disease

diabetes mellitus

Drug Name

AZD1656

Generic Name

AZD1656

Sponsor

AstraZeneca

Drug Status

Discontinued

Phase

II

Start Date

Jan 11, 2009

Study Name

D1020C00019

Study Id

D1020C00019

ClinicalTrials.gov ID

NCT00817778

Recruiting Status

Closed

Protocol Status

Not Available

Report

Feb 24, 2010

• D1020C00019.pdf (120 KB)

Page tools

• Print
• Bookmark this page